CRISPR technologies revolutionized how scientists manipulate genomes. Researchers now easily edit DNA in record time; however, when performing large-scale genome engineering they must choose between introducing one type of edit throughout a genome or creating multiple edits at a single location. Inscripta’s new CRISPR-based technology gives scientists the power to do both in bacteria and yeast, right on their benchtops. The company’s advanced CRISPR-based platform, consisting of an instrument, consumables, software, and assays, offers a fully automated workflow that enables massively parallel, trackable editing of single cells at an unprecedented scale.
Download this ebook from Inscripta to learn about
The Scientist c/o LabX Media Group
1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801
Toll Free: 888.788.0328 | Phone: 705.528.6888
Email: privacy@the-scientist.com
© 1986-2022 The Scientist
The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.